Videos
Dana Goldman, PhD discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children's asthma medication.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Apnimed Submits NDA for AD109 Following Positive Phase 3 Results in Obstructive Sleep Apnea
2
Teclistamab Monotherapy Demonstrates Significant Survival and Response Benefits Versus Standard Regimens in RRMM
3
Iberdomide-Based Quadruplet Induction Followed by Maintenance Achieves High Response and MRD Negativity in NDMM
4
Collaboration, Innovation, Stewardship, and the Future of Infectious Diseases Pharmacotherapy and Practice
5